Cargando…

Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans

Detalles Bibliográficos
Autores principales:	Barber, Cara, Song, Eingun James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136246/ https://www.ncbi.nlm.nih.gov/pubmed/35647249 http://dx.doi.org/10.1016/j.jdcr.2022.04.015

Ejemplares similares

Dermoscopy of Telangiectasia Macularis Eruptiva Perstans
por: Kumar, Smriti, et al.
Publicado: (2019)

Telangiectasia macularis eruptiva perstans in the presence of liver cirrhosis
por: Huang, Alisen, et al.
Publicado: (2020)

Dermatoscopic findings in telangiectasia macularis eruptiva perstans
por: Unterstell, Natasha, et al.
Publicado: (2013)

Telangiectasia macularis eruptiva perstans: more than skin deep
por: Watkins, Casey E., et al.
Publicado: (2011)

Newly Developed Psoriasis in a Patient with Telangiectasia Macularis Eruptiva Perstans and Systemic Mastocytosis Treated with Interferon
por: Péčová, Tatiana, et al.
Publicado: (2021)

Persistent Facial Flushing in a Patient with Telangiectasia Macularis Eruptiva Perstans: An Unusual but Should Emphasized Clinical Finding
por: He, Xigetu, et al.
Publicado: (2022)

Unilateral Facial Telangiectasia Macularis Eruptiva Perstansmimicking as Rosacea
por: Sinha, Preema, et al.
Publicado: (2018)

New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis
por: Barber, Cara, et al.
Publicado: (2022)

Telangiectasia Macularis Eruptive Perstans in an HIV-positive Patient: True Association or Mere Coincidence?
por: Mandal, Rajesh Kumar, et al.
Publicado: (2016)

Rapidly and successful improvement of nail psoriasis with risankizumab
por: Orsini, Diego, et al.
Publicado: (2023)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Palmoplantar Psoriasis Successfully Treated With Risankizumab
por: Alajlan, Abdulmajeed M, et al.
Publicado: (2021)

A case of nail psoriasis improved with treatment by risankizumab
por: AlAjlan, Abdulmajeed, et al.
Publicado: (2022)

Risankizumab for psoriasis
Publicado: (2020)

Nivolumab-induced psoriasis successfully treated with risankizumab-rzaa in a patient with stage III melanoma
por: Glinos, George D., et al.
Publicado: (2021)

Las rocas eruptivas
por: Pomerol, Charles
Publicado: (1963)

Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis
por: Fahmy, Lauren M., et al.
Publicado: (2023)

Risankizumab in the treatment of psoriasis – literature review
por: Banaszczyk, Katarzyna
Publicado: (2019)

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
por: Al Muqrin, Abdullah Muqrin, et al.
Publicado: (2022)

Use of risankizumab in two HIV-positive patients with psoriasis
por: Maliyar, Khalad, et al.
Publicado: (2023)

Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients
por: Pang, Yinuo, et al.
Publicado: (2019)

Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children
por: Kołt-Kamińska, Marta, et al.
Publicado: (2023)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
por: Haugh, Isabel M, et al.
Publicado: (2018)

Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis
por: Reddy, Vidhatha, et al.
Publicado: (2020)

The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infection
por: Song, Eingun James, et al.
Publicado: (2020)

Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation
por: Odnopozova, Liudmila, et al.
Publicado: (2022)

Eruptive lentiginosis in resolving plaque psoriasis during treatment with risankizumab
por: Palmisano, Gerardo, et al.
Publicado: (2023)

Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
por: Witjes, Han, et al.
Publicado: (2019)

Successful treatment of 2 imported cases of Mansonella perstans infection
por: Asgeirsson, Hilmir, et al.
Publicado: (2017)

Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
por: Machado, Álvaro, et al.
Publicado: (2018)

Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: a Report of Two Cases
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Successful long-term maintenance of Mansonella perstans in an in vitro culture system
por: Njouendou, Abdel Jelil, et al.
Publicado: (2017)

Successful treatment of a refractory pyoderma gangrenosum with risankizumab
por: Burgdorf, Birte, et al.
Publicado: (2020)

Successful Treatment of Hereditary Hemorrhagic Telangiectasia With Octreotide
por: Houghton, Kimberly D., et al.
Publicado: (2019)

Risankizumab: COVID-19: case report
Publicado: (2021)

Lichen planus pemphigoides successfully treated with dupilumab
por: Ch’en, Peter Yi, et al.
Publicado: (2022)

Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Risankizumab: Daily Practice Experience of High Need Patients
por: Brunasso, Alexandra M. G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2irih69dgue73pc8s7vie21cm4